Nuclear pharmaceuticals

Ended Awarded

Contract number
HT009022FG1270001
Awardee
Awarding agency
Obligated
$18,427

Award facts

Contract value 100% obligated
$18,426.66 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Dublin, OH 43017, USA

Award details come from SAM.gov/FPDS.

About this award

Cardinal Health 414, LLC was awarded a $18,426 firm fixed price call against the Defense Health Agency's Nuclear Pharmaceuticals blanket purchase agreement to provide nuclear pharmaceutical products and services. As a wholly owned subsidiary of Cardinal Health, Inc., Cardinal Health 414 will deliver the nuclear pharmaceuticals from its Dublin, Ohio facility in support of the Defense Health Agency's medical programs through September 30th, 2022. No set-aside provisions were applied to this award utilizing the Nuclear Pharmaceuticals BPA.

Quick answers

Who was awarded contract HT009022FG1270001?

HT009022FG1270001 was awarded to Cardinal Health 414, LLC by Defense Health Agency (Department of Defense) on December 3, 2021.

How much is contract HT009022FG1270001 worth?

The government has obligated $18,427 on HT009022FG1270001.

Is contract HT009022FG1270001 an order under another contract?

Yes. HT009022FG1270001 is a BPA call under W81K0221A0006, a blanket purchase agreement.

Was contract HT009022FG1270001 competed?

The extent of competition for HT009022FG1270001 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award